News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
MENLO PARK, Calif., June 07, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California Inc., (Nasdaq:PACB) today announced that obtaining microbial genomes with high accuracy and contiguity has become faster and more affordable thanks to new multiplexing tools it will feature at the upcoming American Society for Microbiology (ASM) annual meeting in Atlanta. The increased throughput of... Read more
ASM Microbe Conference 2018 includes over 30 abstracts covering QIAGEN Sample to Insight solutions Germantown, Maryland, and Hilden, Germany, June 7, 2018 – QIAGEN today announced the launch of the QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit with a new generation of reagents to enable the most accurate microbial community profiling from complex microbiome... Read more
HINXTON, United Kingdom and MENLO PARK, Calif., June 06, 2018 (GLOBE NEWSWIRE) — The genomes of more than 3,000 bacteria, including some of the world’s most dangerous, have been sequenced by researchers at the Wellcome Sanger Institute in collaboration with Pacific Biosciences (PacBio). Infecting tens of millions of people worldwide every year, these bacteria have... Read more
Standardizing human sample identification using automated genomic microfluidic systems that reduce hands-on time and cost per sample SOUTH SAN FRANCISCO, Calif., June 05, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ Sample ID Genotyping Panel for the identification and quality assessment of human samples and cell lines in disease research. Maintaining accurate chain-of-custody from sample... Read more
Milestone marks major step toward use of Rapid DNA in police booking stations to dramatically reduce violent crime ANDE® Corporation today announced that its ANDE Rapid DNA™ Identification System has received National DNA Index System (NDIS) approval from the Federal Bureau of Investigation (FBI). The approval allows accredited NDIS laboratories to process DNA samples... Read more
Hilden, Germany; Germantown, Maryland; and Chicago, Illinois, May 31, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with Freenome, a leading artificial intelligence (AI) genomics company, to accelerate the development and commercialization of next-generation sequencing (NGS) tests to enable precision medicine in cancer treatment. The alliance is part of... Read more
Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more
● Introduces pipeline to reach patients more quickly with next-generation sequencing for cancer, in line with modernized regulatory approach from the U.S. Food and Drug Administration ● Announces partnership with Freenome to accelerate companion diagnostics development in immuno-oncology by combining industry-leading artificial intelligence with QIAGEN’s Sample to Insight solutions ● Showcases QIAGEN’s NGS technologies, including... Read more
Employing next-generation Inhibitor Removal Technology and improved sample disruption, the kit boosts the well-known performance of PowerSoil kits in isolating microbial DNA from soils Germantown, Maryland, and Hilden, Germany, May 23, 2018 – QIAGEN today announced the worldwide launch of the new DNeasy PowerSoil Pro Kit, the next generation of sample technology for the extraction of fungal... Read more
Capabilities of the Lexogen RNA-Seq library preparation protocols have been expanded with the launch of 96 i5 x 96 i7 Dual Indexing Barcodes and Unique Molecular Identifiers. We are happy to announce the launch of two new products that complement the Lexogen SENSE and QuantSeq RNA-Seq library preparation protocols. 96 i5 x 96 i7 Dual... Read more